Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study of Cognitive Behavioral Therapy for Anxiety and Bipolar I Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women age 18-65~* DSM-IV diagnosis of bipolar I disorder and at least one of three additional anxiety disorders:~generalized anxiety disorder, panic disorder, or social phobia.~* HAM-D-17 score \<16 (i.e. depressive symptoms)~* YMRS score \< 12 (i.e. no or very low manic symptoms)~* Current, stabilized (\> 3 months) pharmacotherapy treatment under the care of a psychiatrist consisting of optimized, stable maintenance pharmacotherapy at maximum tolerated dosages according to Texas Implementation of Medication Algorithm.~Exclusion Criteria:~* Active suicidality (HAM-D-17 suicide item #3 score \> 3) in the past 2 months. Potential participants scoring 3 or higher on the HAM-D-17 suicide item will be immediately evaluated by the PI and Sponsor and referred to a higher level of care if clinically indicated.~* DSM-IV bipolar I disorder subtype rapid cycling~* DSM-IV manic or mixed episode in the past 2 months~* DSM-IV major depressive episode in the past 2 months~* Psychotropic medication not in accordance with the revised Texas Implementation of Medication Algorithm~* Current Pregnancy~* Medical illness or non-psychiatric medical treatment that would likely interfere with study participation.~* Neurologic disorder, previous ECT, or history of head trauma (i.e. known structural brain lesion)~* Current or past history of selected DSM-IV Axis I disorders other than bipolar disorder including: organic mental disorder, substance abuse within the past 12 months and/or history of substance abuse for \> 1 year; current substance dependence (including alcohol), as assessed by the Structured Clinical Interview for DSM-IV-TR, Substance Use Disorders (Section E); schizophrenia, delusional disorder, psychotic disorders not otherwise specified, obsessive compulsive disorder and posttraumatic stress disorder (due to low prevalence of \~6.5% each).~* Concurrent psychotherapy other than cognitive-behavioral therapy as provided in this study (to rule out other uncontrolled effects of concurrent psychotherapies)~* Presence of metallic implants that would interfere with safety during fMRI scanning (i.e. cardiac pacemaker, metal plates, etc.)~* Claustrophobia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Treatment as usual plus UP CBT (Type: EXPERIMENTAL): Existing psychiatrist-administered psychopharmacotherapy plus weekly transdiagnostic CBT
- Treatment as usual (Type: ACTIVE_COMPARATOR): Existing psychiatrist-administered psychopharmacotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).